Stimulation of soluble interleukin-2 release by tumor necrosis factor-alpha in cancer patients.
Zubelewicz
B
B
Braczkowski
R
R
Rovelli
F
F
Lissoni
P
P
Pittalis
S
S
D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D009369:Neoplasms / Q000097:blood / Q000276:immunology* / Q000628:therapy*; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D012995:Solubility; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha